JESSICA PORTU: Open Payments
NPI 1588651673 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,336 in 172 payments from 43 companies in 2025. Trend: 2023 $3,784 · 2024 $4,632 · 2025 $4,336
Food & beverage: $4,200Education: $136
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 18 | $325 |
| AstraZeneca Pharmaceuticals LP | 12 | $312 |
| Novartis Pharmaceuticals Corporation | 11 | $244 |
| Daiichi Sankyo Inc. | 13 | $226 |
| Incyte Corporation | 4 | $215 |
| Celgene Corporation | 12 | $214 |
| Janssen Biotech, Inc. | 8 | $187 |
| GENZYME CORPORATION | 7 | $176 |
| Astellas Pharma US Inc | 7 | $163 |
| ABBVIE INC. | 6 | $156 |
Products named: REBLOZYL, JAKAFI, PLUVICTO, KEYTRUDA, SARCLISA, RYBREVANT, Enhertu, Optune Lua (NovoTTF-200T).
Industry payments across FL — which companies pay providers there.
